News | Artificial Intelligence | August 19, 2020

FDA Clears AI-based MRI Interpretation Assistants from Siemens Healthineers

AI-Rad Companion Prostate MR for Biopsy Support segments prostate for targeted biopsy under MRI and ultrasound fusion imaging

AI-Rad Companion Prostate MR for Biopsy Support segments prostate for targeted biopsy under MRI and ultrasound fusion imaging

Image courtesy of Clinica Universidad de Navarra, Spain

August 19, 2020 — The Food and Drug Administration (FDA) has cleared two additional Siemens Healthineers artificial intelligence-based software assistants in the AI-Rad Companion family. Both new software assistants free radiologists from routine activities during magnetic resonance imaging (MRI) examinations. The AI-Rad Companion Brain MR for Morphometry Analysis automatically segments the brain in MRI images, measures brain volume, and marks volume deviations. The AI-Rad Companion Prostate MR for Biopsy Support automatically segments the prostate on MRI images and enables radiologists to mark lesions, facilitating targeted prostate biopsies.

“These new AI-Rad Companion applications for MR exams in the brain and prostate regions will help physicians manage their workloads and achieve a patient-focused decision-making process to increase efficiency and improve the quality of care,” said Peter Shen, Vice President of Innovation and Digital Business at Siemens Healthineers North America.

The AI-Rad Companion Brain MR for Morphometry Analysis supports brain volumetry, which involves measuring the volume of gray matter (nerve cells), white matter (nerve cell connections), and cerebrospinal fluid in various segments of the brain and comparing the results to normal volumes. In typical clinical presentation and when combined with independent confirmation, reduced volume may indicate Parkinson’s disease, Alzheimer’s disease, or other forms of dementia.¹ Previously, segmentation and comparison to the norm were performed manually or semi-automatically.

Based on AI algorithms, the AI-Rad Companion Brain MR for Morphometry Analysis can automatically identify roughly 30 brain segments on MRI images, measure their volumes, and compare the results to data in a normative reference database for brain morphometry from the Alzheimer’s Disease Neuroimaging Initiative (ADNI).² The AI-Rad Companion Brain MR for Morphometry Analysis feeds the results into a report where deviations from the norm are marked automatically.

The AI-Rad Companion Prostate MR for Biopsy Support automatically segments the prostate and marks the organ’s outer contour in seconds rather than minutes, as is the case with manual segmentation. The radiologist then simply marks the suspect areas and sends the annotated MRI images to the urologist for fusion with ultrasound images during the biopsy. These targeted, MRI-supported biopsies can help the urologist detect significant prostate carcinomas and improve patient care.

Both new AI-Rad Companion software assistants can be used on MRI scanners from Siemens Healthineers and outside manufacturers, and are available on the teamplay cloud-based digital health platform³ from Siemens Healthineers. These two new assistants join the growing AI-Rad Companion family, which is seamlessly integrated into the existing clinical workflow and is DICOM (Digital Imaging and Communications in Medicine) compliant.

¹ Wolk, D.A., & Dickerson, B.C. (2018). “Clinical features and diagnosis of Alzheimer disease,” UpToDate.com https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-alzheimer-disease?search=Clinical%20features%20and%20diagnosis%20of%20Alzheimer%20disease&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1,

² http://adni.loni.usc.edu/

³ teamplay is not yet commercially available in all countries. For regulatory reasons, its future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for more details.

For more information: www.siemens-healthineers.us/ai-rad

Related Content

Advancements in medical digital technology, rise in prevalence of chronic diseases, development of IT infrastructure, and increase in healthcare expenditure fuel the growth of the global teleradiology market

Getty Images

News | Patient Engagement | September 02, 2020
September 2, 2020 — Allied Market Research published a report, titled, "...
Diagnosing respiratory illness associated with vaping has always been challenging. Adding the spread of COVID-19 and the many similarities in symptoms makes it even more difficult. 

Getty Images

News | Lung Imaging | September 01, 2020
September 1, 2020 — Diagnosing respiratory illness associated with...
Philips announced its next-generation Philips Azurion image-guided therapy platform, marking an important step forward in optimizing clinical and operational lab performance and expanding the role of image-guided interventions in the treatment of patients.
News | Computed Tomography (CT) | September 01, 2020
September 1, 2020 — Philips announced its next-generation ...
Researchers at Karolinska Institutet and Karolinska University Hospital in Sweden have compared the ability of three different artificial intelligence (AI) algorithms to identify breast cancer based on previously taken mammograms. The best algorithm proved to be as accurate as the average radiologist.
News | Breast Imaging | August 28, 2020
August 28, 2020 — Researchers at Karolinska Institutet and Karolinska University Hospital in Sweden have compared the
Electronic cigarette or vaping product use-associated lung injury in a 51-year-old man manifesting as an acute lung injury pattern at CT with subsequent organization.

Electronic cigarette or vaping product use-associated lung injury in a 51-year-old man manifesting as an acute lung injury pattern at CT with subsequent organization. (a, c) Axial unenhanced CT images at presentation through (a) mid and (c) lower lungs show ground-glass opacity with subpleural sparing (arrows); this distribution was present in 45% of chest CT studies at presentation in our cohort (11). (b, d) Axial unenhanced CT images obtained 6 days later show ground-glass opacity has transitioned to consolidation and mild architectural distortion, consistent with developing organization. The patient was initially treated with antibiotics followed by corticosteroid therapy, with slow clinical improvement. Image courtesy of Radiological Society of North America

News | Computed Tomography (CT) | August 27, 2020
August 27, 2020 — Injuries to the lungs from...
The Carestream DRX-L Detector allows capture of long-length images with a single exposure – reducing patient dose, saving exam time, speeding workflow, decreasing repeats and allowing for a higher level of patient comfort.
News | Digital Radiography (DR) | August 27, 2020
August 27, 2020 — The Carestream...
The global pediatric imaging market size is expected to reach $12.2 billion by 2027, registering a CAGR of 7.6% over the forecast period, according to a new report by Grand View Research, Inc.

Getty Images

News | Pediatric Imaging | August 26, 2020
August 26, 2020 — The global ...